347 related articles for article (PubMed ID: 9285411)
1. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules.
Cosman D; Fanger N; Borges L; Kubin M; Chin W; Peterson L; Hsu ML
Immunity; 1997 Aug; 7(2):273-82. PubMed ID: 9285411
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18.
Chapman TL; Heikeman AP; Bjorkman PJ
Immunity; 1999 Nov; 11(5):603-13. PubMed ID: 10591185
[TBL] [Abstract][Full Text] [Related]
3. Human cytomegalovirus, MHC class I and inhibitory signalling receptors: more questions than answers.
Cosman D; Fanger N; Borges L
Immunol Rev; 1999 Apr; 168():177-85. PubMed ID: 10399074
[TBL] [Abstract][Full Text] [Related]
4. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells.
Colonna M; Navarro F; Bellón T; Llano M; García P; Samaridis J; Angman L; Cella M; López-Botet M
J Exp Med; 1997 Dec; 186(11):1809-18. PubMed ID: 9382880
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158).
Long EO; Barber DF; Burshtyn DN; Faure M; Peterson M; Rajagopalan S; Renard V; Sandusky M; Stebbins CC; Wagtmann N; Watzl C
Immunol Rev; 2001 Jun; 181():223-33. PubMed ID: 11513144
[TBL] [Abstract][Full Text] [Related]
6. A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells.
Colonna M; Nakajima H; Navarro F; López-Botet M
J Leukoc Biol; 1999 Sep; 66(3):375-81. PubMed ID: 10496306
[TBL] [Abstract][Full Text] [Related]
7. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
Yusa S; Catina TL; Campbell KS
J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of LIR-2 (ILT4) at 1.8 A: differences from LIR-1 (ILT2) in regions implicated in the binding of the Human Cytomegalovirus class I MHC homolog UL18.
Willcox BE; Thomas LM; Chapman TL; Heikema AP; West AP; Bjorkman PJ
BMC Struct Biol; 2002 Oct; 2():6. PubMed ID: 12390682
[TBL] [Abstract][Full Text] [Related]
9. The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1 + NK cell clones.
Vitale M; Castriconi R; Parolini S; Pende D; Hsu ML; Moretta L; Cosman D; Moretta A
Int Immunol; 1999 Jan; 11(1):29-35. PubMed ID: 10050671
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of leukocyte Ig-like receptor-1 and activating role of UL18 in the response to cytomegalovirus infection.
Wagner CS; Riise GC; Bergström T; Kärre K; Carbone E; Berg L
J Immunol; 2007 Mar; 178(6):3536-43. PubMed ID: 17339449
[TBL] [Abstract][Full Text] [Related]
11. KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2).
Yusa S; Catina TL; Campbell KS
J Immunol; 2004 Jun; 172(12):7385-92. PubMed ID: 15187115
[TBL] [Abstract][Full Text] [Related]
12. Reconstitution of killer cell inhibitory receptor-mediated signal transduction machinery in a cell-free model system.
Cho HI; Park CG; Kim J
Arch Biochem Biophys; 1999 Aug; 368(2):221-31. PubMed ID: 10441372
[TBL] [Abstract][Full Text] [Related]
13. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation.
Binstadt BA; Brumbaugh KM; Dick CJ; Scharenberg AM; Williams BL; Colonna M; Lanier LL; Kinet JP; Abraham RT; Leibson PJ
Immunity; 1996 Dec; 5(6):629-38. PubMed ID: 8986721
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous mutations in the human CMV HLA class I homologue UL18 affect its binding to the inhibitory receptor LIR-1/ILT2/CD85j.
Cerboni C; Achour A; Wärnmark A; Mousavi-Jazi M; Sandalova T; Hsu ML; Cosman D; Kärre K; Carbone E
Eur J Immunol; 2006 Mar; 36(3):732-41. PubMed ID: 16479538
[TBL] [Abstract][Full Text] [Related]
15. The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes.
Fanger NA; Cosman D; Peterson L; Braddy SC; Maliszewski CR; Borges L
Eur J Immunol; 1998 Nov; 28(11):3423-34. PubMed ID: 9842885
[TBL] [Abstract][Full Text] [Related]
16. The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells.
Prod'homme V; Griffin C; Aicheler RJ; Wang EC; McSharry BP; Rickards CR; Stanton RJ; Borysiewicz LK; López-Botet M; Wilkinson GW; Tomasec P
J Immunol; 2007 Apr; 178(7):4473-81. PubMed ID: 17372005
[TBL] [Abstract][Full Text] [Related]
17. Structure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptor.
Yang Z; Bjorkman PJ
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10095-100. PubMed ID: 18632577
[TBL] [Abstract][Full Text] [Related]
18. The major SHP-1-binding, tyrosine-phosphorylated protein in macrophages is a member of the KIR/LIR family and an SHP-1 substrate.
Berg KL; Carlberg K; Rohrschneider LR; Siminovitch KA; Stanley ER
Oncogene; 1998 Nov; 17(19):2535-41. PubMed ID: 9824165
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2).
Chapman TL; Heikema AP; West AP; Bjorkman PJ
Immunity; 2000 Nov; 13(5):727-36. PubMed ID: 11114384
[TBL] [Abstract][Full Text] [Related]
20. Specific recognition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T cells mediates the non-MHC-restricted lysis of human cytomegalovirus-infected cells.
Saverino D; Ghiotto F; Merlo A; Bruno S; Battini L; Occhino M; Maffei M; Tenca C; Pileri S; Baldi L; Fabbi M; Bachi A; De Santanna A; Grossi CE; Ciccone E
J Immunol; 2004 May; 172(9):5629-37. PubMed ID: 15100307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
